UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 1, 2022

Accession Number:	0001193125-22-017127
Submission Type:	POS AM
CIK: 0001434647 Company Name: KEMPHARM, INC File Number: 333-250945